Glenn R. Mattes, President and CEO at TFF Pharmaceuticals, Inc. (TFFP), sold 30,000 shares at $15.33 ($460K) on 2020-12-23, disclosed to the SEC on 2020-12-29.
Open-market sale of $460k TFFP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TFFP | SELL | 2021-03-17 | $852K | — | Filing → |
| TFFP | SELL | 2021-02-18 | $673K | — | Filing → |
| TFFP | SELL | 2021-01-20 | $1.5M | — | Filing → |